Welcome to our dedicated page for Merit Med Sys news (Ticker: MMSI), a resource for investors and traders seeking the latest updates and insights on Merit Med Sys stock.
Merit Medical Systems, Inc. (NASDAQ: MMSI) delivers essential updates for stakeholders tracking innovations in minimally invasive medical devices. This dedicated news hub provides verified information about the company's advancements in cardiology, radiology, and vascular access technologies.
Investors and healthcare professionals will find timely updates on regulatory milestones, product launches, and strategic initiatives. Our curated collection includes earnings reports, clinical trial developments, and partnership announcements that shape Merit Medical's position in the $450B+ global medical device market.
Key coverage areas include new FDA clearances for diagnostic catheters, financial performance across international markets, and innovations in embolization technologies. All content undergoes strict verification to ensure compliance with financial reporting standards and medical industry regulations.
Bookmark this page for direct access to Merit Medical's latest developments in interventional radiology tools, quarterly financial disclosures, and executive leadership updates. For real-time alerts on critical announcements, subscribe to our validated news feed.
Merit Medical (NASDAQ: MMSI) has expanded its embolics portfolio with the FDA-cleared Siege Vascular Plug and the launch of Bearing nsPVA Express Prefilled Syringe in the US and Australia. These products complement existing microsphere, particle, and foam offerings. The Siege Vascular Plug, available in three sizes, offers rapid vessel occlusion within 1.3 minutes, enhancing precision in peripheral artery treatments. The Bearing nsPVA Express, a 20-mL prefilled syringe, simplifies procedures by saving time and reducing waste. Both products will be showcased at the 18th Annual GEST Meeting (May 16-19, 2024) in New York, where Merit will also exhibit other embolic solutions and delivery systems.
Merit Medical Systems, Inc. reported strong financial performance for Q1 2024 with a revenue increase of 8.7% to $323.5 million compared to Q1 2023. The company's GAAP operating margin improved to 11.1%, GAAP EPS rose to $0.48, and non-GAAP EPS increased to $0.77. Merit reaffirmed its fiscal year 2024 guidance with expectations of continued growth and profitability.
FAQ
What is the current stock price of Merit Med Sys (MMSI)?
What is the market cap of Merit Med Sys (MMSI)?
